ASP Isotopes (NASDAQ:ASPI) Given Buy Rating at Canaccord Genuity Group

Canaccord Genuity Group reaffirmed their buy rating on shares of ASP Isotopes (NASDAQ:ASPI) in a research report sent to investors on Friday morning, Benzinga reports. The brokerage currently has a $4.50 target price on the stock.

Several other equities research analysts also recently issued reports on ASPI. HC Wainwright lowered their price target on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Canaccord Genuity Group initiated coverage on ASP Isotopes in a research report on Friday, October 4th. They issued a “buy” rating and a $4.50 price target on the stock.

ASP Isotopes Trading Up 5.9 %

ASP Isotopes stock opened at $4.28 on Friday. The company has a debt-to-equity ratio of 2.06, a current ratio of 4.00 and a quick ratio of 4.00. The company has a market capitalization of $221.55 million, a price-to-earnings ratio of -8.08 and a beta of 5.11. ASP Isotopes has a one year low of $0.98 and a one year high of $5.67. The company’s fifty day moving average price is $2.66 and its two-hundred day moving average price is $3.25.

ASP Isotopes (NASDAQ:ASPI) last issued its quarterly earnings results on Monday, August 19th. The company reported ($0.24) earnings per share (EPS) for the quarter. The firm had revenue of $1.02 million during the quarter. On average, analysts forecast that ASP Isotopes will post -0.24 earnings per share for the current fiscal year.

Institutional Investors Weigh In On ASP Isotopes

Several hedge funds have recently made changes to their positions in ASPI. Vanguard Group Inc. lifted its stake in shares of ASP Isotopes by 479.1% in the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock valued at $4,217,000 after buying an additional 844,705 shares during the period. Marshall Wace LLP lifted its stake in shares of ASP Isotopes by 389.6% in the second quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock valued at $1,668,000 after buying an additional 433,734 shares during the period. Bank of New York Mellon Corp bought a new stake in shares of ASP Isotopes in the second quarter valued at about $381,000. HTLF Bank lifted its stake in ASP Isotopes by 197.0% during the second quarter. HTLF Bank now owns 105,538 shares of the company’s stock worth $323,000 after purchasing an additional 70,000 shares during the period. Finally, Virtu Financial LLC lifted its stake in ASP Isotopes by 477.0% during the first quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock worth $346,000 after purchasing an additional 69,176 shares during the period. Institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.